HomeBusinessAltria shares rose, but is the stock a buy?

Altria shares rose, but is the stock a buy?

Shares of Altria (NYSE:MO) have had a great run this past year, gaining over 30% in value. The Q3 2024 earnings particularly excited investors, with shares rebounding sharply after the release. But is Altria’s business really that good? To answer that question, you have to dig into the numbers a bit. But you only have to scratch the surface before you realize that the long-term picture may not be as good as management would have you believe.

It’s important to take a step back and understand the core businesses in which Altria operates. Through the first nine months of 2024, the company generated approximately $18 billion in revenue. Of that total, smokable products brought in $15.9 billion in revenue, or about 88% of the total. Smokable products include both cigarettes and cigars, with cigarettes accounting for approximately 98% of the volume. Within the cigarette sector, the Marlboro brand accounted for just over 90% of the volume. All this very clearly leads to the fact that Altria is a high-end brand cigarette manufacturer.

Start your morning smarter! Wake up with Breakfast news in your inbox every market day. Register for free »

Image source: Getty Images.

But right now, Altria is spending a lot of time highlighting the NJOY vaping business it recently acquired. It’s the first ‘division’ discussed in detail in the company’s Q3 2024 earnings release. It makes sense for Altria to emphasize the positives. And there are big positives about NJOY, but you have to take them with a grain of salt.

See also  Dow and S&P 500 are reeling after warmer-than-expected inflation data

For example, in the third quarter, NJOY’s consumables volume increased 15.6% compared to the same quarter a year ago. NJOY device shipments increased by over 100%! And NJOY gained 2.8 share points in its product category year over year. That’s all very good news, but NJOY works from a small base. Just by connecting NJOY to Altria’s distribution system, a rapid performance improvement can be expected. In other words, the product’s growth is good news, but given the situation, it’s not surprising news in any way.

MO chart
MO chart

This is where investors need to be more critical. The company celebrates its best qualities while trying to downplay its worst. And while NJOY is a bright spot, it’s so small that the revenue it generates is classified as “other.” The “other” category on the income statement, for reference, accounted for far less than 1% of revenue in the third quarter, despite all that growth in NJOY management that investors were talking about. It’s not even a rounding error.

- Advertisement -
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments